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Summary  Manganese-enhanced  MRI  (MEMRI)  has  been  considered  a  surrogate  marker  of  Ca+2
inﬂux  into  activated  cells  and  tracer  of  neuronal  active  circuits.  However,  the  induction  of  status
epilepticus  (SE)  by  kainic  acid  does  not  result  in  hippocampal  MEMRI  hypersignal,  in  spite  of
its  high  cell  activity.  Similarly,  short  durations  of  status  (5  or  15  min)  induced  by  pilocarpine
did  not  alter  the  hippocampal  MEMRI,  while  30  min  of  SE  even  reduced  MEMRI  signal  Thus,  this
study  was  designed  to  investigate  possible  explanations  for  the  absence  or  decrease  of  MEMRI
signal  after  short  periods  of  SE.  We  analyzed  hippocampal  caspase-3  activation  (to  evaluate
apoptosis), T2 relaxometry  (tissue  water  content)  and  aquaporin  4  expression  (water-channel
protein)  of  rats  subjected  to  short  periods  of  pilocarpine-induced  SE.  For  the  time  periods
studied  here,  apoptotic  cell  death  did  not  contribute  to  the  decrease  of  the  hippocampal  MEMRI
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signal.  However,  T2 relaxation  was  higher  in  the  group  of  animals  subjected  to  30  min  of  SE  than
in the  other  SE  or  control  groups.  This  result  is  consistent  with  higher  AQP-4  expression  during  the
same time  period.  Based  on  apoptosis  and  tissue  water  content  analysis,  the  low  hippocampal
MEMRI signal  30  min  after  SE  can  potentially  be  attributed  to  local  edema  rather  than  to  cell
death.
© 2014  Elsevier  B.V.  All  rights  reserved.
Introduction
Status  epilepticus  (SE)  is  deﬁned  as  a  seizure  that  persists  for
a  sufﬁcient  length  of  time  or  is  repeated  frequently  enough
that  recovery  between  attacks  does  not  occur  (CCT-ILAE,
1981).  This  deﬁnition  was  based  on  the  persistence  or  repe-
tition  of  the  epileptic  seizures  rather  than  on  the  duration,
although  experts  agreed  that  it  should  last  at  least  30  min  to
evoke  a  chronic  epileptic  condition  (Lemos  and  Cavalheiro,
1995).
In  the  pilocarpine  model  of  temporal  lobe  epilepsy  (TLE),
SE  onset  is  deﬁned  as  a  seizure  that  persists  for  at  least
5  min,  and  usually  it  may  persist  from  4  to  24  h  (Leite  et  al.,
1990).  Electroencephalographical  (EEG)  recordings  immedi-
ately  after  intraperitonial  pilocarpine  injection  have  shown
that  low-voltage,  fast  activity  appears  in  the  neocortex  and
amygdala,  while  theta  rhythm  is  evident  in  the  hippocam-
pus.  As  the  behavioral  manifestation  of  seizures  becomes
more  severe,  the  theta  hippocampal  activity  is  replaced
by  high-voltage  spiking  and  fast  activity.  EEG  recordings
immediately  after  injection  have  shown  that  pilocarpine  can
induce  ictal  epileptic  events  and  that  these  EEG  patterns  are
correlated  with  behavioral  changes  that  culminate  into  SE
[for  review,  see  (Curia  et  al.,  2008)].
MRI  is  a  noninvasive  and  high  resolution  imaging  modality
that  is  considered  the  most  sensitive  and  speciﬁc  structural
neuroimaging  for  epilepsy,  allowing  several  neuropatho-
logical  studies.  There  are  many  MRI  techniques:  T2-  and
T1-weighted  imaging,  functional  MRI,  manganese  enhanced
MRI  (MEMRI),  arterial  spin  labeling  (ASL),  diffusion  tensor
imaging  (DTI)  that  can  detect  not  only  damage  caused  by
status  epilepticus  but  also  plastic  changes  in  the  brain  that
occur  in  response  to  damage  [for  review,  see  (Gröhn  et  al.,
2011)].
Manganese-enhanced  magnetic  resonance  imaging
(MEMRI)  is  based  on  the  fact  that  Mn+2 is  a  paramagnetic
substance  that  changes  both  transverse  and  longitudinal
relaxation  (Korestky  and  Silva,  2004;  Silva  et  al.,  2004) and
thus  can  act  as  a  contrast  agent  in  magnetic  resonance
imaging  (MRI).  The  ability  of  Mn+2 to  compete  with  Ca+2
allows  it  to  be  a  marker  of  increased  cellular  activity  and
to  trace  neuronal  connections  (Korestky  and  Silva,  2004;
Pautler  et  al.,  1998).
Many  animal  studies  have  found  a  strong  correlation
between  local  brain  activity  and  manganese  enhancement
using  speciﬁc  stimuli  and  MnCl2 systemically  injected  with
and  without  transient  breakdown  of  the  blood—brain  bar-
rier  (BBB)  (Kuo  et  al.,  2006;  Lin  and  Koretsky,  1997;  Pautler
and  Koretsky,  2002;  Weng  et  al.,  2007;  Yu  et  al.,  2005).  This
ability,  added  to  the  fact  that  Mn+2 clearly  enhances  the
various  subﬁelds  of  the  hippocampus  (dentate  gyrus  (DG),
CA1  (Cornu  Ammonis)  and  CA3  (Aoki  et  al.,  2004;  Watanabe
et  al.,  2004),  suggests  that  MEMRI  could  act  as  an  imaging
marker  of  epileptic  focus.
Considering  the  chronic  phase  of  epilepsy  in  the  kainate
or  pilocarpine  models,  recent  reports  provide  evidence
that  the  MEMRI  hyperintensity  in  the  DG  is  mostly  corre-
lated  with  mossy  ﬁber  sprouting  (Immonen  et  al.,  2008;
Malheiros  et  al.,  2012b;  Nairismägi  et  al.,  2005),  or,
alternatively,  inversely  correlated  with  the  frequency  of
spontaneous  recurrent  seizures  (Dedeurwaerdere  et  al.,
2013).  Although  conﬂicting,  these  ﬁndings  relate  the  MEMRI
signal  in  the  hippocampus  to  local  increases  of  cell  activity.
However,  it  has  been  shown  that  manganese  enhancement
of  the  MRI  signal  is  signiﬁcantly  decreased  in  the  hip-
pocampus  in  the  acute  and  latent  phases  of  the  kainate
model  (Alvestad  et  al.,  2007).  These  last  results  could  be
either  attributed  to  cell  damage  or  loss  following  the  long
duration  of  SE  (Alvestad  et  al.,  2007;  Immonen  et  al.,
2008).  In  an  attempt  to  circumvent  the  possible  causes
of  reduction  in  the  MEMRI  signal  during  SE  (cell  dam-
age/loss),  the  status  was  fully  blocked  at  progressive  time
periods  after  its  onset  (5,  15  or  30  min)  and  the  cell
activity  and  the  MEMRI  signal  were  evaluated.  It  resulted
that  short  durations  of  status  did  not  produce  differences
in  the  MEMRI  signal  (30  min  of  SE  reduced  MEMRI  sig-
nal)  despite  increased  c-fos  expression  (Malheiros  et  al.,
2012a).
Based  on  these  ﬁndings,  the  present  study  will  further
investigate  possible  causes  (apoptosis  cell  death  or  tissue
water  content)  for  reduction  of  the  MEMRI  signal  during  SE
induced  by  pilocarpine.
Methods
Animals  and  study  design
All  protocols  were  approved  by  the  Animal  Care  Com-
mittee  of  the  Universidade  Federal  de  São  Paulo  (CEP
0750/07).  Adult  male  Wistar  rats  (250—300  g)  were  housed
4  rats/cage  and  kept  under  controlled  laboratory  conditions
(12  h  light/12  h  dark  cycle  with  lights  on  at  07:00  a.m.,  tem-
perature  22  ±  1 ◦C,  air  humidity  50—60%,  ad  libitum  access
to  food  and  water).  Pilocarpine  hydrochloride  (300  mg/kg,
i.p.  Vegeﬂora,  Parnaiba,  Brazil)  was  systemically  injected,
and  30  min  prior,  animals  were  given  scopolamine  methyl
bromide  (1  mg/kg,  i.p.,  Sigma,  Saint  Louis,  MI,  US)  to  reduce
systemic  cholinergic  side  effects.  Pilocarpine  animals  devel-
oped  SE  on  average  30  min  after  the  injection.  One  hundred
two  animals  were  used  in  this  study.  The  SE-related  mortal-
ity  was  22.3%  and  24.7%  of  animals  that  received  pilocarpine
injection  did  not  develop  SE.
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Fig.  1  Temporal  diagram  depicting  the  groups,  treatments,  and  procedures  used  in  the  present  study.  The  animals  were  divided
into six  groups:  Groups  1—4  received  a  solution  of  MnCl2·4H2O  (60  mg/kg)  12  h  prior  to  pilocarpine  injection.  Group  1  (n  =  6  for
each time  period)  and  Group  3  (n  =  4  for  each  time  period)  were  designed  to  compare  MEMRI  contrast  with  c-fos  expression  and
caspase-3 assay,  respectively  after  SE.  Groups  2  (n  =  8)  and  4  (n  =  4)  served  as  controls  for  Groups  1  and  3,  respectively.  These  groups
underwent the  same  protocol  but  did  not  receive  pilocarpine  injections.  Group  5  (n  =  5  for  each  time  period)  received  pilocarpine
and Group  6  (n  =  5)  did  not  experience  SE.  These  groups  were  used  without  MnCl2 injection,  and  T2-weighted  MRI  was  acquired  to
compare their  aquaporin-4  expression.  Abbreviations:  M-esc—–scopolamine  methyl  bromide;  SE—–Status  epilepticus;  AQ4—–aquaporin
4; Pilo—–pilocarpine  and  thio  +  dz—–thionembutal  +  diazepam.
The  study  design  is  outlined  in  Fig.  1.  Rats  were  divided
into  6  experimental  groups.  Awake  animals  for  Groups  1—4
received  a  solution  of  MnCl2·4H2O  (1  M)  diluted  in  bicine
solution  (100  mM  in  deionized  water)  with  pH  adjusted  to
7.4  using  NaOH.  Final  concentration  of  MnCl2 was  100  mM.
Freshly  prepared  MnCl2 (60  mg/kg)  was  injected  intraperi-
toneally  12  h  prior  to  pilocarpine  injection  when  Mn+2 has
already  reached  the  hippocampus  and  the  Mn+2 accumula-
tion  is  still  ongoing  (Lee  et  al.,  2005).
Behavioral  seizures  development  was  observed  based  on
the  Racine  scale  (Racine,  1972).  The  SE  onset  was  deﬁned
after  5  min  of  continuous  seizure  activity.  At  the  end  of
different  SE  time  periods  (5,  15  or  30  min),  all  the  exper-
imental  groups,  including  the  controls,  received  a  mixture
of  thionembutal  +  diazepam  (30  +  10  mg/kg,  i.p.).  Behavioral
analysis  in  this  paper  supports  previous  encephalographic
results  (Mello  et  al.,  2006)  showing  that  this  mixture  termi-
nates  the  SE  in  up  to  10  min.
Group  1  (n  =  6  for  each  time  period)  and  Group  3  (n  =  4
for  each  time  period)  was  designed  to  compare  MEMRI  with
c-fos  expression  and  caspase-3  assay,  respectively,  after  SE.
Group  2  (n  =  8)  and  Group  4  (n  =  4)  served  as  controls  for
Group  1  and  Group  3,  respectively.  They  underwent  the
same  protocol  but  did  not  experience  SE  (did  not  receive  the
pilocarpine  injection).  Group  5  (n  =  5  for  each  time  period)
received  pilocarpine  and  Group  6  (n  =  5)  did  not  experience
SE.  These  groups  were  not  MnCl2 injected,  and  T2-weighted
MRI  was  acquired  to  compare  their  aquaporin-4  expression.
For  Groups  1  and  2  we  used  exactly  the  same  protocols  as
previously  published  (Malheiros  et  al.,  2012a).
MRI
All  MRI  (T1 and  T2-weighted)  were  acquired  14  h  after
MnCl2. To  decrease  the  post-SE  mortality  rate,  the  animals
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Fig.  2  Hippocampal  MEMRI  for  pilocarpine  injected  animals  in  the  acute  phase  5,  15  and  30  min  after  SE.  T1-weighted  MEMRI
images (A  and  C)  and  MEMRI  data  (B).  The  regions  of  interest  (ROIS)  were  drawn  in  the  hippocampal  sub  regions  DG  (dentate  gyrus),
CA1 and  CA3  (Cornu  Ammonis),  as  represented  in  A.  The  DG  was  enlarged  and  converted  from  gray  into  a  colored  scale  in  C  to  show
differences between  the  CTR  and  SE30  groups  (* P  <  0.01).  (For  interpretation  of  the  references  to  color  in  this  ﬁgure  legend,  the
reader is  referred  to  the  web  version  of  this  article.)
(even  controls  treated  with  the  mixture  of  thionembu-
tal  +  diazepam,  as  above  described)  were  placed  in  a  supine
position  on  the  surgical  table,  tracheotomised,  intubated
(tube  with  approximately  0.5  mm  diameter),  and  connected
to  a  respirator  for  small  animals  (model  7025,  Ugo  Basile)
and  ventilated  with  ambient  air  (21%  FiO2),  at  a  respiratory
rate  of  70  cycles/min  and  a  volume  of  3.5  mL/cycle.  These
ventilatory  parameters  were  monitored  during  the  image
acquisitions  according  to  physiological  parameters  of  each
animal.
Images  were  obtained  in  a  2  T/30  cm  superconducting
magnet  85310HR  (Oxford  Instruments,  Abingdon,  UK)  inter-
faced  with  a  Bruker  Avance  AVIII  console  (Bruker-Biospin,
Inc.,  Billerica,  MA,  USA)  using  Paravision  5.0  software.  A
crossed  saddle  radiofrequency  coil  (Papoti,  2006)  was  used
as  a  head  probe.  T1-weighted  FLASH  (Fast  Low-Angle  Shot)
sequence  was  used  in  animals  (Groups  1—4)  that  were
MnCl2 injected  (TR  =  200  ms,  TE  =  5.8  ms,  ﬂip  angle  =  90◦,
4  means,  40  min/animal).  A  volume  of  40  ×  40  ×  11.2  mm3
was  covered  with  a  192  ×  192  ×  16  points,  generating  a
spatial  resolution  of  208  ×  208  ×  700  m3.  T2 MSME  (Multi
Slice  Multi  Echo)  sequence  was  acquired  in  Groups  5  and  6
with  208  ×  208  m2 spatial  resolution  to  determine  the  hip-
pocampal  T2 relaxation  time  (4  averages;  TR  =  2000  ms,  15
equally  spaced  echoes,  TE  =  15—225  ms;  FOV  =  40  ×  40  mm,
19  min/animal).
MRI  data  was  analyzed  using  the  Paravision  5.0  soft-
ware.  One  author  (JMM),  blinded  to  the  group’s  identity  has
manually  outlined  the  regions  of  interest  (ROI).  Alterations
in  the  relative  signal  intensity  of  the  dentate  gyrus  (DG),
CA1  (Cornu  Ammonis)  and  CA3  were  quantiﬁed  from  a  single
coronal  section  in  T1-weighted  3D  images  at  the  antero-
posterior  level  of  −3.6  mm  from  the  bregma  (Fig.  2A).  The
signals  were  calculated  as  the  ratio  between  the  inten-
sity  of  the  mean  signal  in  the  ROI  and  the  intensity  of
the  mean  signal  of  the  adjacent  corpus  callosum  (baseline
value).  The  increased  intensity  of  the  relative  signal,  when
compared  to  control  animals,  was  determined  as  MEMRI
hyperintensity.  A  ROI  utilized  in  this  study,  denominated
DG,  in  reality  includes  the  DG  and  the  proximal  portion
of  the  CA3,  because  it  was  not  possible  to  separate  them
for  analysis  (Immonen  et  al.,  2008).  T2 relaxation  time  was
determined  by  drawing  bilaterally  the  contour  of  the  hip-
pocampus  to  deﬁne  the  region  of  interest  (ROI)  on  the  MSME
images.  The  hippocampal  level  was  the  same  as  used  in  the
analysis  of  T1-weighted  images  (3.6  mm  caudal  to  bregma).
The  software  tool  ISA  (Image  Sequence  Analysis)  was  used
and  the  T2 calculated  from  a  monoexponential  curve.
Brain  tissue
C-fos  immunohistochemistry
Animals  for  Groups  1  and  2  were  perfused  transcardially,  just
after  MRI  acquisitions,  with  saline  followed  by  4%  formalde-
hyde  in  0.1  M  phosphate  buffer  (PB,  Sigma-Aldrich,  pH  7.4).
After  perfusion,  the  brains  were  then  removed  from  the
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skull  and  stored  at  4 ◦C  in  30%  sucrose  for  3—4  days.  Coro-
nal  sections  with  30  m  were  cut  on  a  cryostat  and  one
of  three  consecutive  coronal  sections  was  pre-treated  with
hydrogen  peroxidase,  followed  by  normal  goat  serum  (1:200)
and  0.3%  Triton  X-100  for  30  min.  Sections  were  then  (1)
incubated  with  primary  antibody  (rabbit  anti  c-Fos  1:3000;
Vector  Laboratories,  CA)  at  room  temperature  for  24  h;  (2)
incubated  with  a  secondary  antibody  (goat  anti-rabbit  IgG
1:200;  Vector  Laboratories,  CA)  for  2  h  at  room  temperature;
(3)  treated  with  1:100  avidin—biotin  complex  for  90  min
and  a  nickel-intensiﬁed  diaminobenzidine  reaction.  The  sec-
tions  were  rinsed  in  phosphate  buffer,  dried  and  mounted  on
gelatin-coated  slides  and  coverslipped.
Histological  images  were  captured  on  a  high-resolution
digital  camera  (Nikon  DXM1200),  installed  in  a  Nikon
microscope  (Eclipse  E600FN)  with  a  magniﬁcation  of
10×.  Immunohistochemical  labeling  of  c-Fos  in  the  DG,
CA1  and  CA3  was  evaluated  by  quantitatively  measuring
grayscale  values  using  the  National  Institutes  of  Health  (NIH)
Image  J  software  (http://rsbweb.nih.gov/ij/index.html).
The  grayscale  values  for  the  hippocampal  sub  regions  were
compared  to  those  for  the  adjacent  corpus  callosum  (base-
line  value).  Sections  were  assessed  across  three  different
levels  (rostral,  medium,  and  caudal)  of  the  hippocampus
bilaterally,  corresponding  to  levels  2.8,  3.8,  and  4.8  mm  cau-
dal  to  the  bregma  (Paxinos  and  Watson,  1998) to  exclude  any
possible  rostro-caudal  variability.
Caspase-3  ﬂuorimetric  assay
Caspase-3  activity  was  studied  in  n  =  4  animals  per  group
using  the  method  described  by  Thornberry  et  al.  (1997)
recently  modiﬁed  by  Belizário  et  al.  (2001).  Rats  were
decapitated  just  after  MRI  acquisitions  with  animals  still
under  the  effects  of  anaesthetic.  The  hippocampi  were
dissected  at  4 ◦C  and  immediately  added  to  20  mM  HEPES
buffer  (pH  7.4)  that  contained  2  mM  EDTA,  0.1%  CHAPS,  10%
sucrose,  0.1%  PMSF,  0.1%  benzamidin,  0.1%  antipain,  0.1%
TLCK,  0.1%  chemostatin  and  0.1%  pepstatin  (5  ml  homog-
enization  buffer/mg  tissue).  Homogenates  were  obtained
by  mechanically  disrupting  the  tissue  three  times  on
dry-ice,  with  thawing  in  an  ice  bath,  interpolated  by
1  min  of  moderate  vortex  shaking.  Samples  were  cen-
trifuged  at  12,000  ×  g  for  40  min  at  4 ◦C  to  remove  cellular
debris.  Total  proteins  were  determined  in  the  supernatants
using  the  Bio—Rad  Protein  Assay  (Bio-Rad  Labs,  Germany).
Homogenates  (100  mg/protein)  were  incubated  at  37 ◦C  with
the  tetrapeptide  substrate:  AspGlu-Val-Asp  (Ac-DEVD-AMC,
4  mM)  for  caspase-3,  in  a  ﬁnal  volume  of  150  ml.  For  a nega-
tive  control,  homogenates  were  pre-incubated  for  10  min  at
37 ◦C  with  commercial  inhibitor  to  caspase-3  (Ac-DEVD-CHO,
1  mM),  followed  by  the  addition  of  the  respective  substrate.
Activity  was  measured  continuously  over  2  h  on  a  FlexStation
3  (Molecular  Probes)  Spectroﬂuorimeter,  using  ex =  360  nm
and  em =  465  nm.  Results  are  expressed  in  activity  (nmol
AMC).
Aquaporin  4  expression  assay
Brain  tissues  were  homogenized  in  ice-cold  isolation  solution
(200  mM  mannitol,  80  mM  HEPES,  41  mM  KOH,  pH  7.5)  con-
taining  protease  inhibitor  cocktail.  The  homogenates  were
centrifuged  at  low  speed  (4000  ×  g)  for  15  min  at  4 ◦C  to
remove  nuclei  and  cell  debris.  Protein  concentrations  were
determined  by  the  Bradford  assay  method  (Bio-Rad  Protein
Assay  kit;  Bio-Rad  Laboratories,  Hercules,  CA).
Brain  samples  were  run  on  12%  polyacrylamide
minigels.  After  transfer  by  electroelution  to  a  hydrophobic
polyvinylidene  diﬂuoride  membrane  (Amersham  Hybond-P
PVDF  Membrane  GE  Healthcare,  Buckinghamshire,  UK),
blots  were  blocked  with  5%  milk  and  0.1%  Tween  20  in  TBS  or
1  h.  Blots  were  then  incubated  overnight  with  an  anti-AQP4
(Santa  Cruz,  TX,  US)  antibody  (1:10,000).  The  labeling
was  visualized  with  a horseradish  peroxidase-conjugated
secondary  antibody  (anti-rabbit  IgG  diluted  1:2000;  Sigma)
using  Western  blotting  detection  reagents,  the  enhanced
chemiluminescence  detection  system  ECL  (GE  Healthcare,
Buckinghamshire,  UK).  The  images  were  obtained  using  the
chemiluminescence  imaging  system  Alliance  4.2  (Uvitec,
Cambridge,  UK)  and  quantitative  analysis  of  antibodies
was  performed  using  densitometry,  normalizing  the  bands
to  actin  (Santa  Cruz,  Texas,  US;  1:2000  with  anti-goat
1:10,000)  expression.
Statistical  analysis
All  data  are  presented  as  the  mean  ±  SEM  (standard  error
of  mean).  A  one-way  analysis  of  variance  (ANOVA)  was  fol-
lowed  by  the  Bonferroni  post  hoc  test  with  the  statistical
signiﬁcance  set  to  P  <  0.05  for  each  analysis.
Results
MEMRI
In  the  dentate  gyrus  (DG)  the  MEMRI  signal  was  similar  among
the  SE5  (1.008  ±  0.008),  SE15  (1.011  ±  0.010)  and  control
(CTR)  groups  (1.031  ±  0.012)  (Fig.  2B).  In  the  same  region,
the  SE30  MEMRI  signal  (0.979  ±  0.007,  P  <  0.01)  was  less  than
that  of  the  CTR  (Fig.  2B  and  C).
In  the  CA1  (Cornu  Ammonis)  ﬁeld,  the  groups
SE5  (0.938  ±  0.007),  SE15  (0.947  ±  0.004)  and  SE30
(0.943  ±  0.008)  displayed  a  MEMRI  signal  similar  to  that  of
the  control  group  (0.961  ±  0.011).
In  the  CA3  ﬁeld,  as  for  the  DG  region,  the  MEMRI  signal
was  similar  among  SE5  (0.981  ±  0.007),  SE15  (0.993  ±  0.013)
and  control  (1.010  ±  0.014)  groups.  However,  the  MEMRI  sig-
nal  of  the  SE30  group  (0.953  ±  0.015)  was  signiﬁcantly  lower
than  the  CTR  (P  <  0.05).
C-fos
Fig.  3  shows  c-Fos  immunohistochemical  labeling  in  the  DG
(A-D)  region,  CA1  (E-H)  and  CA3  (I-L)  ﬁelds.  The  densitome-
try  analysis  of  c-fos  labelled  cells  indicated  that  in  the  DG,
more  c-fos  expressing  cells  occur  in  the  SE5  (41.1  ±  4.5),
SE15  (40.8  ±  5.8)  and  SE30  (40.3  ±  5.5)  groups  than  in  the
control  (10.3  ±  0.8,  P  <  0.05).  Similar  results  were  observed
in  the  CA1  and  CA3  ﬁelds.  In  the  CA1  ﬁeld,  the  mean
number  of  c-fos  labeled  cells  in  the  SE5  (26.9  ±  2.3),  SE15
(31.8  ±  2.5)  and  SE30  (25.9  ±  3.6)  groups  is  higher  than  in
the  control  one  (10.9  ±  0.7,  P  <  0.05);  in  the  CA3  ﬁeld  the
mean  number  of  c-fos  immunolabeled  cells  was  similarly
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Fig.  3  Hippocampal  histological  analysis  of  c-fos  expression  (gray  scale  values)  for  DG  (A—D),  CA1  (E—H)  and  CA3  (I—L)  for  control
(CTR), SE5,  SE15  and  SE30  groups,  respectively.  Pilocarpine-treated  animals  showed  intense  staining  in  all  hippocampal  sub  regions
unlike the  controls.
higher  after  status,  despite  its  duration  (SE5,  20.8  ±  2.0;
SE15,  23.3  ±  2.7;  SE30,  19.5  ±  2.4)  than  in  the  control  group
(8.7  ±  0.7,  P  <  0.05).
No  differences  in  the  number  of  c-fos  positively  labelled
cells  were  detected  among  pilocarpine-treated  groups  (SE5,
SE15  and  SE30)  for  any  hippocampal  sub  region.
Caspase-3
Fig.  4A  summarizes  ﬂuorimetric  caspase-3  activity  (nmol
AMC).  There  were  no  differences  between  all  stud-
ied  groups:  SE5,  129.2  ±  9.4;  SE15,  148.9  ±  19.7;  SE30,
153.0  ±  8.4  and  CTR,  140.6  ±  19.6.
T2  relaxometry
Hippocampal  MRI  relaxometry  (ms)  ﬁndings  are  summa-
rized  in  Fig.  4B.  There  were  no  differences  between  SE5
(62.3  ±  1.9)  and  SE15  (60.7  ±  1.9)  groups  when  compared  to
control  group  (58.4  ±  2.6).  In  addition,  T2 in  the  SE30  group
(70.4  ±  2.2)  is  higher  than  in  the  control  (P  <  0.01)  and  SE15
(P  <  0.05)  groups.
Aquaporin-4  (AQP-4)
Aquaporin-4  expression,  as  measured  by  means  of  densitom-
etry,  was  higher  in  the  SE30  (120.6  ±  4.7)  group  than  in  the
control  (95.2  ±  5.6,  P  <  0.05)  or  SE15  (89.2  ±  8.4,  P  <  0.05),
but  similar  to  the  SE5  (105.5  ±  0.95)  group.  There  were
no  other  differences  between  groups.  Results  are  shown  in
Fig.  4C  and  D.
Discussion and conclusion
The  MEMRI  and  c-fos  expression  data  presented  here  are
consistent  with  our  own  and  others’  previous  data,  which
showed  decrease  in  relative  signal  intensity  in  T1-weighted
MEMRI  images  in  the  hippocampus  during  pilocarpine  and
kainate  SE  (Alvestad  et  al.,  2007;  Immonen  et  al.,  2008;
Malheiros  et  al.,  2012a).  There  are  no  identiﬁed  MEMRI
differences  between  pilocarpine-treated  animals  (SE5  and
SE15)  and  controls  for  the  dentate  gyrus  (DG),  CA1  (Cornu
Ammonis)  and  CA3  ﬁelds.
The  experiments  conducted  here  aimed  to  add  some
light  to  the  proposed  role  of  MEMRI  as  preclinical  biomarker
for  the  severity  of  epileptogenesis  in  animal  models.  Hip-
pocampal  MEMRI  signal  in  the  epileptic  chronic  phase  was
proposed  to  be  related  to  local  increases  of  cell  activity  after
seizures  (Dedeurwaerdere  et  al.,  2013).  Although  the  man-
ganese  enhancement  was  related  to  spontaneous  seizures
outcome  in  the  chronic  epilepsy  phase,  it  does  not  seem  to
happen  after  acute  induced  seizures.  It  is  noteworthy  that
the  SE30  group  displayed  a  decrease  MEMRI  signal  even  in
the  DG  and  CA3  areas,  which  contrasts  with  the  high  cell
activity  in  all  hippocampal  sub  regions  (DG,  CA1  and  CA3)
conﬁrmed  by  c-fos  expression.  Immediate  early  gene  c-fos
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Fig.  4  Hippocampal  caspase-3  and  AQP4  results.  (A)  Caspase-3  activity  was  the  same  for  both  pilocarpine  and  control  (CTR)
groups. In  (B),  SE30  showed  a  T2 (ms)  value  higher  than  the  CTR  (* P  <  0.01)  and  SE15  (# P  <  0.05).  AQP4  results:  (C)  AQP4  protein
expression (around  35  kDa)  in  different  groups  identiﬁed  by  Western-blotting  and  (D)  grayscale  values  obtained  from  (C),  indicating
that AQP4  expression  was  different  between  SE30  ×  CTR  (* P  <  0.05)  and  SE30  ×  SE15  (# P  <  0.05)  groups.
is  a  marker  of  neurons  that  have  been  recently  active,  e.g.,
during  a  seizure  (Sheng  and  Greenberg,  1990).  Therefore,
the  absence  of  hippocampal  MEMRI  for  SE30  and  MEMRI  sig-
nal  similar  to  controls  for  SE5  and  SE  15  cannot  be  attributed
to  decreased  neuronal  activity.
One  possible  explanation  for  the  absence  of  MEMRI  sig-
nal  in  the  hippocampus  for  SE30  could  be  related  to  cell
loss,  once  in  vivo  MEMRI  enhancement  is  proportional  to
the  Mn+2 taken  into  cells  through  voltage  gated  Ca+2 chan-
nels  (Silva  et  al.,  2004).  However,  our  current  results  show
that  there  is  no  alteration  in  the  levels  of  caspase-3  activ-
ity  after  pilocarpine-induced  status,  during  the  time  period
investigated  here.  Caspase-3  activation  is  a  mechanism  of
cell  death  (apoptosis)  induced  by  seizures  and  has  been
detected  between  24  h  and  7  days  after  pilocarpine-induced
status  epilepticus  (SE)  in  neurons,  primarily  in  the  hip-
pocampus  (Weise  et  al.,  2005),  although  other  studies  have
shown  that  active  caspase-3  occurs  mainly  in  the  astro-
cytes  and  to  a  lesser  extent  in  neurons  (Ferrer  et  al.,
2000;  Narkilahti  et  al.,  2003).  Regardless  of  which  hip-
pocampal  cell  population  is  more  affected  by  caspase-3
activation,  it  was  not  detectable  within  a  few  hours  after
SE  onset,  thus  suggesting  that  after  different  durations
of  status  (5,  15  or  30  min),  apoptotic  cell  death  is  not
related  to  reduction  of  MEMRI  signal  in  the  hippocam-
pus.
In  addition  to  cell  death,  local  edema  is  often  found  in
epileptic  hippocampus,  so  it  could  by  itself  alter  the  MEMRI
signal  output.  The  current  results  indicate  that  T2 signal
hyperintensity  is  indeed  present  in  SE30  group,  but  not  in
the  earlier  time  periods.  This  is  maybe  due  to  increases
of  water  content  in  the  hippocampus  reducing  the  man-
ganese  signal.  The  hippocampus  of  patients  with  mesial
temporal  lobe  epilepsy  is  often  hardened  and  shrunken,  a
condition  known  as  sclerosis.  Magnetic  resonance  imaging
(MRI)  reveals  an  increase  in  the  T2-weighted  signal,  whereas
the  diffusion-weighted  imaging  shows  a  higher  apparent
diffusion  coefﬁcient  in  sclerotic  hippocampi,  indicative  of
an  increased  water  ﬂow  into  the  hippocampus,  and  accu-
mulation  of  water  in  the  brain  parenchyma.  In  another
human  study,  hippocampal  edema  and  neuronal  cell  loss
appear  together  (Kumar  et  al.,  2013).  Therefore,  a  sig-
niﬁcant  increase  in  aquaporin-4  (AQP-4)  was  observed  in
sclerotic,  but  not  in  non-sclerotic,  hippocampi  obtained
from  patients  with  medically  intractable  temporal  lobe
epilepsy  (Lee  et  al.,  2004).  For  animals,  SE  induced  by  kainic
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acid  indicate  signiﬁcantly  greater  tissue  edema  (AQP-4)  and
T2  MRI  changes  (Lee  et  al.,  2012).
AQP-4  is  a  water-channel  protein  expressed  strongly  in
the  brain,  predominantly  in  astrocyte  foot  processes  at  the
borders  between  the  brain  parenchyma  and  major  ﬂuid  com-
partments,  including  cerebrospinal  ﬂuid  (CSF)  and  blood.
This  distribution  suggests  that  AQP-4  controls  water  ﬂuxes
into  and  out  of  the  brain  parenchyma  (Papadopoulos  and
Verkman,  2007).  In  interstitial  edema,  AQP-4  might  facili-
tate  the  removal  of  excess  extracellular  brain  water  (Bloch
et  al.,  2006;  Bloch  et  al.,  2005;  Papadopoulos  et  al.,  2004).
Here,  the  AQP-4  protein  expression  was  higher  in  the  SE30
group  than  in  the  other  studied  groups.  The  result  obtained
by  AQP-4  in  the  SE30  group  is  consistent  with  T2 relaxation
changes  found  in  the  same  time  period,  indicating  the  rela-
tionship  of  both  measures  with  brain  edema.
In  conclusion,  the  DG  and  CA3  MEMRI  hypo  signal  seen
in  the  SE30  group  could  be  explained  by  increases  of  water
content  rather  than  cell  death.  We  suggest  that  the  T2 relax-
ation  changes  are  attributable  to  brain  edema.  Decreases  in
brain  edema  and/or  cellular  swelling  could  be  mediated  by
AQP-4,  resulting  in  better  clearance  of  water  excess  from
brain  tissue.  The  hippocampal  edema  presented  after  30  min
of  status  changes  the  MRI  relaxation  times  so  that,  the  MEMRI
signal  was  lower  than  in  control  group,  thereby  presenting
a  hypo  signal  on  T1-weighted  images.
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